The AMPICLOX brand, founded in 2006 (United Kingdom), from 1722 sister brands and 17477 competing brands. AMPICLOX is a brand of GSK PLC, listed on the stock exchange of Francfort. The International Securities Identification Number (ISIN) of GSK PLC is GB00BN7SWP63. AMPICLOX is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
GSK PLC
(AMPICLOX)
over 5 years*
EUR 15.74